Literature DB >> 19878672

Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose.

Ashraf Taye1, Adel H Saad, Arun Hs Kumar, Henning Morawietz.   

Abstract

Hyperglycemia-induced generation of reactive oxygen species contributes to the development of proatherogenic changes and vasculopathy in diabetes. NADPH oxidase has been recognized as a major source of reactive oxygen species in the vasculature and the lectin-like oxLDL receptor-1 (LOX-1) appears to play a crucial role in the pathogenesis of diabetic endothelial dysfunction. The present study aimed to examine the relationships between the hyperglycemia-mediated NADPH oxidase-LOX-1 pathway activation and nitric oxide-mediated endothelial function. In addition, we investigated effect of the NADPH oxidase inhibitor, apocynin on these consequences. In human umbilical artery endothelial cells (HUAECs), the effect of high glucose on expressional regulations and functional consequences of NADPH oxidase subunits, LOX-1 and endothelial nitric oxide synthase (eNOS), in the absence and presence of apocynin (10 micromol/l) were evaluated. HUAECs were cultured under normal (5.5 mmol/l) or high glucose (30mmol/l) concentrations for 48 h in the absence and presence of apocynin. Our results showed that high glucose significantly enhanced the activity and the protein expression of NADPH oxidase subunits, Nox2 and p47(phox). High glucose markedly increased LOX-1 mRNA level and this was functionally reflected on the augmented uptake of Dil-labelled LDL (5 micromol/l, 3h) by HUAECs. Furthermore, high glucose attenuated eNOS protein and total nitrite levels. However, apocynin inhibited all these changes. Collectively, our study demonstrates that high glucose-induced oxidative stress via NADPH oxidase activation and this contributed to LOX-1 upregulation and eNOS downregulation in human endothelial cells. Apocynin efficiently reversed these consequences, suggesting its potential role as a vasculoprotective agent. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878672     DOI: 10.1016/j.ejphar.2009.10.045

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  23 in total

Review 1.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

Review 2.  Angiotensin II and vascular injury.

Authors:  Augusto C Montezano; Aurelie Nguyen Dinh Cat; Francisco J Rios; Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2014-06       Impact factor: 5.369

Review 3.  Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.

Authors:  Sanjiv Singh; Avtar Singh Gautam
Journal:  Curr Atheroscler Rep       Date:  2019-07-27       Impact factor: 5.113

4.  Peroxynitrite mediates diabetes-induced endothelial dysfunction: possible role of Rho kinase activation.

Authors:  Azza B El-Remessy; Huda E Tawfik; Suraporn Matragoon; Bindu Pillai; Ruth B Caldwell; R William Caldwell
Journal:  Exp Diabetes Res       Date:  2010-11-01

Review 5.  The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update.

Authors:  Hanrui Zhang; Kevin C Dellsperger; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2011-12-22       Impact factor: 17.165

6.  Spironolactone improves endothelial dysfunction in streptozotocin-induced diabetic rats.

Authors:  Heba Adel; Ashraf Taye; Mohamed M A Khalifa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-09-20       Impact factor: 3.000

7.  Apocynin improves oxygenation and increases eNOS in persistent pulmonary hypertension of the newborn.

Authors:  Stephen Wedgwood; Satyan Lakshminrusimha; Kathryn N Farrow; Lyubov Czech; Sylvia F Gugino; Fernando Soares; James A Russell; Robin H Steinhorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-23       Impact factor: 5.464

8.  RANKL treatment of vascular endothelial cells leading to paracrine pro-calcific signaling involves ROS production.

Authors:  Emma Harper; Keith D Rochfort; Diarmuid Smith; Philip M Cummins
Journal:  Mol Cell Biochem       Date:  2019-11-14       Impact factor: 3.396

9.  Experimental evidence for the therapeutic potential of tempol in the treatment of acute liver injury.

Authors:  Mekky M Abouzied; Heba M Eltahir; Ashraf Taye; Mahran S Abdelrahman
Journal:  Mol Cell Biochem       Date:  2015-10-06       Impact factor: 3.396

10.  Tempol ameliorates cardiac fibrosis in streptozotocin-induced diabetic rats: role of oxidative stress in diabetic cardiomyopathy.

Authors:  Ashraf Taye; Mekky M Abouzied; Omar M M Mohafez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-08-16       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.